Pitt Shield

Clinical Intervention Using Focused Ultrasound (FUS) Stimulation of the Brain in Diverse Neurological Disorders.

Authors: Baek H, Lockwood D, Mason EJ, Obusez E, Poturalski M, Rammo R, Nagel SJ, Jones SE

Various surgical techniques and pharmaceutical treatments have been developed to improve the current technologies of treating brain diseases. Focused ultrasound (FUS) is a new brain stimulation modality that can exert a therapeutic effect on diseased brain cells, with this effect ranging from permanent ablation of the pathological neural circuit to transient excitatory/inhibitory modulation of the neural activity depending on the acoustic energy of choice. With the development of intraoperative imaging technology, FUS has become a clinically available noninvasive neurosurgical option with visual feedback. Over the past 10 years, FUS has shown enormous potential. It can deliver acoustic energy through the physical barrier of the brain and eliminate abnormal brain cells to treat patients with Parkinson's disease and essential tremor. In addition, FUS can help introduce potentially beneficial therapeutics at the exact brain region where they need to be, bypassing the brain's function barrier, which can be applied for a wide range of central nervous system disorders. In this review, we introduce the current FDA-approved clinical applications of FUS, ranging from thermal ablation to blood barrier opening, as well as the emerging applications of FUS in the context of pain control, epilepsy, and neuromodulation. We also discuss the expansion of future applications and challenges. Broadening FUS technologies requires a deep understanding of the effect of ultrasound when targeting various brain structures in diverse disease conditions in the context of skull interface, anatomical structure inside the brain, and pathology.

Introduction

Purpose Other
Study Objective To review the current FDA-approved and emerging clinical applications, mechanisms, and future challenges of focused ultrasound (FUS) for treating neurological disorders.

Outcomes and Safety

Summary of Outcomes Focused ultrasound produces therapeutic effects from permanent thermal ablation (clinically effective as MRgFUS unilateral thalamotomy for essential tremor and unilateral pallidotomy for Parkinson's disease) to transient excitatory/inhibitory neuromodulation and blood–brain barrier (BBB) opening to enable localized drug or cell delivery. Successful approaches reported include high‑energy MRgFUS thermal ablation (FDA‑approved applications) and lower‑energy, imaging‑guided FUS BBB‑opening and neuromodulation protocols (often microbubble‑assisted), though specific acoustic parameter values were not uniformly specified in this review.
Duration of biological effect permanent
Safety-related matter The provided text does not mention any safety data or adverse effects; no adverse events or safety concerns are reported in the excerpt.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics focal depth: None; focal length: None; aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search